Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for October 2016. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Opioid Poisonings in Children, Teens Rising Dramatically
MONDAY, Oct. 31, 2016 (HealthDay News) -- The number of young children and teens hospitalized for overdosing on opioids has increased nearly two-fold in recent years, according to a study published online Oct. 31 in JAMA Pediatrics.
Full Text
Guidelines Presented for Fluoroquinolone Use in Children
MONDAY, Oct. 31, 2016 (HealthDay News) -- In a clinical report published online Oct. 31 in Pediatrics, guidelines are presented for the use of systemic and topical fluoroquinolones in children.
Full Text
Questionnaire, Peak Flow Can ID Undiagnosed COPD
MONDAY, Oct. 31, 2016 (HealthDay News) -- A five-item questionnaire plus peak expiratory flow (PEF) can identify undiagnosed chronic obstructive pulmonary disease (COPD), according to a study published online Oct. 26 in the American Journal of Respiratory and Critical Care Medicine.
Full Text (subscription or payment may be required)
Timely Antibiotic Administration Cuts Death in Cirrhosis, UGIB
MONDAY, Oct. 31, 2016 (HealthDay News) -- Timely administration of antibiotics is associated with a reduction in mortality among patients with cirrhosis and upper gastrointestinal bleeding (UGIB), according to a study published in the November issue of Clinical Gastroenterology and Hepatology.
Full Text (subscription or payment may be required)
Few Changes in Employer-Sponsored Insurance 2013-2014
MONDAY, Oct. 31, 2016 (HealthDay News) -- Private sector employer-sponsored health insurance offerings were similar in 2013 and 2014, with <3.5 percent of employers dropping coverage and 1.1 percent adding coverage, according to a report published online Oct. 26 in Health Affairs.
Abstract
Full Text
Low-Dose Isotretinoin Therapeutic for Seborrhea
MONDAY, Oct. 31, 2016 (HealthDay News) -- For patients with moderate-to-severe seborrhea and seborrheic dermatitis, low-dose oral isotretinoin can be therapeutic, according to a study published online Oct. 25 in the International Journal of Dermatology.
Full Text (subscription or payment may be required)
Diabetes-Related Distress Ups Risk for Rx Nonadherence
MONDAY, Oct. 31, 2016 (HealthDay News) -- Diabetes-related distress and depression symptom severity are risk factors for medication nonadherence in type 2 diabetes, according to a study published online Oct. 17 in Diabetes Care.
Full Text (subscription or payment may be required)
Skin Patch to Treat Peanut Allergy Appears Promising
FRIDAY, Oct. 28, 2016 (HealthDay News) -- A skin patch that delivers small amounts of peanut protein may help treat children and young adults with peanut allergy, according to a study published online Oct. 26 in the Journal of Allergy and Clinical Immunology.
Full Text (subscription or payment may be required)
Male Contraceptive Effective, but Side Effects Problematic
FRIDAY, Oct. 28, 2016 (HealthDay News) -- A contraceptive injection for men shows some promise, but researchers are still struggling to improve its effectiveness and deal with severe side effects caused by the injections, according to a study published online Oct. 27 in the Journal of Clinical Endocrinology & Metabolism.
Abstract
Full Text
Education Needed Regarding Use of Herbal Weight Loss Products
FRIDAY, Oct. 28, 2016 (HealthDay News) -- Health care professionals need education about the safety and effectiveness of weight loss medications, according to a study published online Oct. 22 in the Journal of Pharmacy Practice and Research.
Full Text (subscription or payment may be required)
Subconjunctival Gentamicin Can Cause Macular Necrosis
THURSDAY, Oct. 27, 2016 (HealthDay News) -- Subconjunctival gentamicin can cause macular necrosis in the eye, according to a letter to the editor published online Oct. 20 in Clinical & Experimental Ophthalmology.
Full Text (subscription or payment may be required)
Quality Improvement Methods Improve Asthma Care
THURSDAY, Oct. 27, 2016 (HealthDay News) -- Implementation of quality improvement (QI) methods can improve timely administration of short-acting β-agonists (SABAs) for acute asthma in a pediatric emergency department, according to a study published online Oct. 26 in Pediatrics.
Full Text (subscription or payment may be required)
Lower Costs for Pregabalin in Peripheral Neuropathic Pain
THURSDAY, Oct. 27, 2016 (HealthDay News) -- For patients with peripheral neuropathic pain (PNP), the adjusted cost per patient is lower for treatment with pregabalin than gabapentin, according to a study published online Sept. 27 in the Journal of Evaluation in Clinical Practice.
Full Text
Cancer Survivors Have Higher Rate of Antidepressant Use
THURSDAY, Oct. 27, 2016 (HealthDay News) -- Treatment for depression and anxiety is nearly twice as common among U.S. cancer survivors as it is for those with no history of cancer, according to a study published online Oct. 26 in the Journal of Clinical Oncology.
Full Text
FDA Warns of Testosterone, AAS Abuse and Dependence
WEDNESDAY, Oct. 26, 2016 (HealthDay News) -- Supplemental testosterone and related anabolic-androgenic steroids (AAS) can cause heart attacks, personality changes, and infertility, and are easily abused, the U.S. Food and Drug Administration warns, adding that labeling on all prescription testosterone products will be revised.
More Information
Statins Offset Insulin-Related Cancer Risk in T2DM
WEDNESDAY, Oct. 26, 2016 (HealthDay News) -- For patients with type 2 diabetes mellitus (T2DM), use of statins offsets insulin-related cancer risks, according to research published online Oct. 21 in the Journal of Internal Medicine.
Full Text (subscription or payment may be required)
Heart Failure Care Up, Regardless of Hospital Teaching Status
WEDNESDAY, Oct. 26, 2016 (HealthDay News) -- Adherence to performance measures is similar at teaching hospitals (TH) and nonteaching hospitals (NTH), according to a study published online Oct. 25 in Circulation: Cardiovascular Quality and Outcomes.
Abstract
Full Text (subscription or payment may be required)
Review: No Clear Link for Calcium Supplements, CVD
TUESDAY, Oct. 25, 2016 (HealthDay News) -- Calcium supplements, taken within recommended levels, can be considered safe for the heart, according to new guidelines and an evidence review published online Oct. 25 in the Annals of Internal Medicine.
Clinical Practice Guideline
Evidence Review
Editorial (subscription or payment may be required)
Narrow-Spectrum Abx Feasible in Healthcare-Associated Pneumonia
TUESDAY, Oct. 25, 2016 (HealthDay News) -- It may be safe to switch from broad- to narrow-spectrum antibiotic coverage once hospitalized patients with healthcare-associated pneumonia reach clinical stability, according to a study published online Oct. 3 in the Annals of the American Thoracic Society.
Full Text (subscription or payment may be required)
Rx Subsidy Ups Persistence to Breast Cancer Hormone Therapy
TUESDAY, Oct. 25, 2016 (HealthDay News) -- For white, black, and Hispanic women, receipt of a prescription subsidy is associated with improved persistence to breast cancer hormone therapy, according to a study published online Oct. 17 in the Journal of Clinical Oncology.
Abstract
Full Text (subscription or payment may be required)
Liraglutide Increases Heart Rate in T2DM With Stable CAD
TUESDAY, Oct. 25, 2016 (HealthDay News) -- Liraglutide increases heart rate (HR) and reduces heart rate variability (HRV) in overweight patients with newly diagnosed type 2 diabetes (T2D) and stable coronary artery disease (CAD), according to a study published online Oct. 19 in Diabetes Care.
Full Text (subscription or payment may be required)
Saxagliptin Linked to Improved Albumin/Creatinine Ratios
MONDAY, Oct. 24, 2016 (HealthDay News) -- For patients with type 2 diabetes, saxagliptin is associated with improvement in the albumin/creatinine ratio (ACR), according to a study published online Oct. 17 in Diabetes Care.
Full Text (subscription or payment may be required)
Continued 2 Percent Daily Testosterone Safe, Effective
MONDAY, Oct. 24, 2016 (HealthDay News) -- Once-daily testosterone solution 2 percent (T-sol) is safe and improves sex drive and energy in men with androgen deficiency, according to a study published in the November issue of The Journal of Urology.
Full Text
Guidance for Coronary Patients With ASA/NSAID Sensitivity
MONDAY, Oct. 24, 2016 (HealthDay News) -- In patients with stable chronic ischemic heart disease (CIHD) and histories of nonsevere hypersensitivity reactions to acetylsalicylic acid (ASA)/nonsteroidal anti-inflammatory drugs (NSAIDs), an ASA challenge is recommended, according to a study published online Oct. 12 in Allergy.
Full Text (subscription or payment may be required)
Resveratrol Doesn't Improve Insulin Sensitivity
MONDAY, Oct. 24, 2016 (HealthDay News) -- Resveratrol supplementation does not improve hepatic or peripheral insulin sensitivity among patients with type 2 diabetes, according to a study published online Oct. 7 in Diabetes Care.
Full Text (subscription or payment may be required)
Acidic Skin Care Product Beneficial in Older Adults
FRIDAY, Oct. 21, 2016 (HealthDay News) -- For older adults, an acidic skin care product with different plant oils improves epidermal barrier formation and increases lipid lamellae in the intercellular space of the stratum corneum (SC), according to a study published online Oct. 12 in the International Journal of Cosmetic Science.
Full Text (subscription or payment may be required)
Switching Diet Drinks for Water Benefits Overweight Women
FRIDAY, Oct. 21, 2016 (HealthDay News) -- For overweight and obese women with type 2 diabetes, replacement of diet beverages (DBs) with water is associated with greater weight reduction and improvements in glucose metabolism, according to a study published online Oct. 16 in Diabetes, Obesity and Metabolism.
Full Text (subscription or payment may be required)
Bundled-Payment Program Deemed Better for Breast CA Care
FRIDAY, Oct. 21, 2016 (HealthDay News) -- For breast cancer care, a bundled-payment program is associated with better adherence to quality indicators and better outcomes over time compared with a fee-for-service (FFS) program, according to a study published online Oct. 19 in JAMA Oncology.
Full Text
Editorial
pCR of 37 Percent for Topical Imiquimod in Lentigo Maligna
FRIDAY, Oct. 21, 2016 (HealthDay News) -- For patients with lentigo maligna (LM) in-situ melanoma, topical imiquimod has a pathological complete regression (pCR) rate of 37 percent, according to a study published online Oct. 6 in the British Journal of Dermatology.
Full Text (subscription or payment may be required)
CDC: Two Doses of HPV Vaccine Sufficient for Children Under 15
THURSDAY, Oct. 20, 2016 (HealthDay News) -- Children 14 and younger require only two doses of the human papillomavirus (HPV) vaccine rather than the previously recommended three doses, according to the U.S. Centers for Disease Control and Prevention.
More Information
Open-Label Placebo Treatments Can Ease Chronic Low Back Pain
THURSDAY, Oct. 20, 2016 (HealthDay News) -- Patients who knowingly took a placebo pill while undergoing traditional treatment for lower back pain had less pain and disability than those who received traditional treatment alone, according to a study published online Oct. 13 in Pain.
Full Text (subscription or payment may be required)
Resveratrol Reduces Ovarian, Adrenal Androgens in PCOS
THURSDAY, Oct. 20, 2016 (HealthDay News) -- For patients with polycystic ovary syndrome (PCOS), resveratrol is associated with significant reductions in ovarian and adrenal androgens, according to a study published online Oct. 18 in the Journal of Clinical Endocrinology & Metabolism.
Abstract
Full Text
FDA Approves New Treatment for Advanced Soft Tissue Sarcoma
WEDNESDAY, Oct. 19, 2016 (HealthDay News) -- Lartruvo (olaratumab) has been approved by the U.S. Food and Drug Administration to treat adults with certain soft tissue sarcomas.
More Information
Certain Factors Predict Repeat ER Visits for Ureteral Stones
WEDNESDAY, Oct. 19, 2016 (HealthDay News) -- Among patients with ureteral stones, those who are younger, have proximal stones, and require intravenous narcotics for pain control are more likely to return to the emergency department within 30 days, according to a study published in the November issue of The Journal of Urology.
Full Text (subscription or payment may be required)
Financial Toxicity Is a Relevant Cancer Outcome Measure
WEDNESDAY, Oct. 19, 2016 (HealthDay News) -- Financial toxicity is a clinically relevant outcome for patients receiving treatment for advanced cancer, according to a study published online Oct. 7 in Cancer.
Full Text
Researchers Find Antidepressant Bupropion Crosses Placenta
WEDNESDAY, Oct. 19, 2016 (HealthDay News) -- In pregnant women taking the antidepressant bupropion, the drug and its active metabolites cross the placenta to the fetal circulation, according to a study published in the October issue of the American Journal of Obstetrics & Gynecology.
Full Text (subscription or payment may be required)
Researchers Say Not All A-Fib Patients Need Anticoagulation
TUESDAY, Oct. 18, 2016 (HealthDay News) -- Some patients with atrial fibrillation who have implanted pacemakers or defibrillators may not always need anticoagulation, according to a study published online Oct. 17 in Circulation.
Full Text (subscription or payment may be required)
Postprandial Walk Beneficial in Type 2 Diabetes
TUESDAY, Oct. 18, 2016 (HealthDay News) -- For patients with type 2 diabetes, a short walk after eating may help lower blood glucose levels more than exercising at other times of the day, according to research published online Oct. 17 in Diabetologia.
Full Text 1 (subscription or payment may be required)
Full Text 2 (subscription or payment may be required)
AHA Urges Awareness of Statin Interaction With Other CV Meds
TUESDAY, Oct. 18, 2016 (HealthDay News) -- Statins can interact with other drugs prescribed for cardiovascular disease, but there are ways to navigate the issue, according to new recommendations from the American Heart Association published online Oct. 17 in Circulation.
Full Text (subscription or payment may be required)
Herbal, Dietary Supplements Cause One-Fifth of Hepatotoxicity
TUESDAY, Oct. 18, 2016 (HealthDay News) -- Herbal and dietary supplement (HDS)-induced liver injury accounts for 20 percent of cases of hepatotoxicity in the United States, according to research published online Sept. 27 in Hepatology.
Full Text (subscription or payment may be required)
HBV, HCV Coinfection Ups Non-Hodgkin Risk in ART-Treated HIV
TUESDAY, Oct. 18, 2016 (HealthDay News) -- Chronic coinfection with hepatitis B virus (HBV) and hepatitis C virus (HCV) is associated with non-Hodgkin's lymphoma (NHL) among patients with HIV receiving antiretroviral treatment (ART), according to a study published online Oct. 18 in the Annals of Internal Medicine.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Spironolactone Benefits Exercise Tolerance in HFpEF
TUESDAY, Oct. 18, 2016 (HealthDay News) -- For patients with heart failure with preserved ejection fraction (HFpEF) with an exercise-induced increase in the ratio between early mitral inflow velocity and mitral annular early diastolic velocity (E/e'), spironolactone is associated with improved exercise capacity, according to a study published in the Oct. 25 issue of the Journal of the American College of Cardiology.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Topotecan-Based Therapy Beneficial for Retinoblastoma
TUESDAY, Oct. 18, 2016 (HealthDay News) -- For patients with advanced retinoblastoma, topotecan combined with vincristine, carboplatin, and aggressive focal therapies is effective, according to a study published online Oct. 10 in the Journal of Clinical Oncology.
Abstract
Full Text (subscription or payment may be required)
Considerable Economic Burden for Vaccine-Preventable Diseases
TUESDAY, Oct. 18, 2016 (HealthDay News) -- For U.S. adults, the economic burden associated with vaccine-preventable diseases was estimated at about $9 billion in 2015, according to a study published in the October issue of Health Affairs.
Abstract
Full Text (subscription or payment may be required)
Quality of Outpatient Care Has Not Consistently Improved in U.S.
MONDAY, Oct. 17, 2016 (HealthDay News) -- Efforts to improve the quality of clinical care in the United States have had little impact on many aspects of outpatient care, according to an analysis published online Oct. 17 in JAMA Internal Medicine.
Full Text
Editorial
Adolescent BMI Predicts Diabetes Mellitus Mortality
MONDAY, Oct. 17, 2016 (HealthDay News) -- Adolescent body mass index (BMI) predicts diabetes mellitus (DM) mortality in midlife, according to a study published online Oct. 12 in Diabetes Care.
Full Text (subscription or payment may be required)
CDC: Complementary Health Use Up With Musculoskeletal Pain
MONDAY, Oct. 17, 2016 (HealthDay News) -- Use of complementary health approaches is significantly higher for U.S. adults with musculoskeletal pain disorders, according to a report published online Oct. 12 in the U.S. Centers for Disease Control and Prevention's National Health Statistics Reports.
Full Text
Data Mining, Experiments ID QT Prolonging Drug Interactions
MONDAY, Oct. 17, 2016 (HealthDay News) -- Data mining coupled with laboratory experiments can identify QT interval-prolonging drug-drug interactions (QT-DDIs), according to a study published in the Oct. 18 issue of the Journal of the American College of Cardiology.
Full Text
Editorial (subscription or payment may be required)
Early Births Down With 17α-Hydroxyprogesterone Caproate
MONDAY, Oct. 17, 2016 (HealthDay News) -- For women with a prior preterm birth, cerclage plus 17α-hydroxyprogesterone caproate is associated with a significant reduction in delivery at less than 24 weeks of gestation compared with cerclage alone, according to a study published in the November issue of Obstetrics & Gynecology.
Full Text (subscription or payment may be required)
Alemtuzumab May Reverse Some Disability in Newly-Diagnosed MS
FRIDAY, Oct. 14, 2016 (HealthDay News) -- The multiple sclerosis (MS) drug alemtuzumab, usually reserved for patients in the late stages of the disease, seems to offer long-term remission in newly diagnosed patients, according to a study published online Oct. 12 in Neurology.
Abstract
Full Text
Editorial (subscription or payment may be required)
DEA Halts Move to Ban Controversial Herbal Kratom
FRIDAY, Oct. 14, 2016 (HealthDay News) -- Bowing to public pressure, the U.S. Drug Enforcement Administration has halted a move to ban a plant called kratom, which experts say could help battle the nation's opioid epidemic.
More Information
Inhaled Levodopa May Rapidly Relieve Parkinson's Symptoms
THURSDAY, Oct. 13, 2016 (HealthDay News) -- An inhaled version of the Parkinson's drug levodopa can help when patients experience symptoms between doses of the pill form of the medication, according to a study published in the Oct. 12 issue of Science Translational Medicine.
Full Text
Low Diastolic Pressure Linked to Subclinical Myocardial Damage
THURSDAY, Oct. 13, 2016 (HealthDay News) -- Low diastolic blood pressure (DBP) seems to be associated with subclinical myocardial damage, according to a study published in the Oct. 18 issue of the Journal of the American College of Cardiology.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Calcium Supplements May Be Detrimental to Heart Health
WEDNESDAY, Oct. 12, 2016 (HealthDay News) -- Dietary calcium in the form of supplements, but not calcium-rich foods, might have a harmful impact on the heart, according to a study published online Oct. 11 in the Journal of the American Heart Association.
Full Text
SSRI Use During Pregnancy Tied to Speech Issues in Offspring
WEDNESDAY, Oct. 12, 2016 (HealthDay News) -- Children whose mothers used a selective serotonin reuptake inhibitor (SSRI) during pregnancy may be more likely to develop speech and language disorders, according to a study published online Oct. 12 in JAMA Psychiatry.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Some Antihypertensives Linked to Depression, Bipolar Risk
WEDNESDAY, Oct. 12, 2016 (HealthDay News) -- Some antihypertensive medications may increase the risk that patients will be hospitalized for depression and bipolar disorder, according to a study published online Oct. 10 in Hypertension.
Abstract
Full Text
Social Reintegration of Hodgkin's Survivors Impeded by Fatigue
WEDNESDAY, Oct. 12, 2016 (HealthDay News) -- Severe fatigue (sFA) can impede social reintegration in Hodgkin's lymphoma (HL) survivors, according to a study published online Oct. 3 in the Journal of Clinical Oncology.
Abstract
Full Text
Most Anaphylaxis Patients in ER Treated Appropriately
WEDNESDAY, Oct. 12, 2016 (HealthDay News) -- The majority of anaphylaxis patients seeking treatment in Belgian emergency departments are treated in accordance with the European Academy of Allergy and Clinical Immunology (EAACI) guidelines, according to a study published Oct. 6 in Allergy.
Full Text (subscription or payment may be required)
Trends in Dietary Supplement Use Among U.S. Adults Changing
TUESDAY, Oct. 11, 2016 (HealthDay News) -- Use of traditional multivitamins is decreasing among Americans, while supplements such as vitamin D, fish oil, and probiotics are becoming more popular, according to a study published in the Oct. 11 issue of the Journal of the American Medical Association.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Placebo Effect Seen in Chiropractic Tx of Migraine
TUESDAY, Oct. 11, 2016 (HealthDay News) -- Real and sham chiropractic spinal manipulative therapy (CSMT) are equally likely to ease patients' migraine pain, according to a study published online Oct. 2 in the European Journal of Neurology.
Full Text
DEET to Protect Against Zika Appears Safe During Pregnancy
TUESDAY, Oct. 11, 2016 (HealthDay News) -- N,N-diethyl-meta-toluamide (DEET) insect repellents won't harm a pregnant woman or her fetus when used as instructed to prevent Zika infection, according to research published in the November issue of Obstetrics & Gynecology.
Full Text (subscription or payment may be required)
Costs of Chemo for Breast Cancer Vary Widely in the United States
TUESDAY, Oct. 11, 2016 (HealthDay News) -- Breast cancer chemotherapy costs can vary by tens of thousands of dollars in the United States, depending on the course of treatment doctors select, according to a study published online Oct. 10 in Cancer.
Full Text (subscription or payment may be required)
CDI Risk Up When Prior Occupant of Hospital Bed Got Antibiotics
TUESDAY, Oct. 11, 2016 (HealthDay News) -- When a hospital patient is taking antibiotics, the next patient to use the same bed may face an elevated risk of Clostridium difficile infection (CDI), according to a study published online Oct. 10 in JAMA Internal Medicine.
Full Text
Radiomic-Based Method Predicts Recurrent Glioblastoma Outcome
TUESDAY, Oct. 11, 2016 (HealthDay News) -- A radiomic-based approach can be used to generate a prediction model for stratifying treatment outcome among patients with recurrent glioblastoma prior to bevacizumab treatment, according to a study published online Oct. 10 in Clinical Cancer Research.
Full Text (subscription or payment may be required)
Copay Assist Programs Creating Problems in Health Care Markets
TUESDAY, Oct. 11, 2016 (HealthDay News) -- Despite offering assistance to individuals who cannot afford expensive medications, copay assistance programs create broader problems in health care markets, according to an Ideas and Opinions piece published online Oct. 11 in the Annals of Internal Medicine.
Full Text (subscription or payment may be required)
Not Enough Men Who Have Sex With Men Aware of PrEP
MONDAY, Oct. 10, 2016 (HealthDay News) -- Many men who have sex with men (MSM) are not aware that pre-exposure prophylaxis (PrEP) medication can protect them from HIV, according to a study published online Sept. 28 in the American Journal of Preventive Medicine.
Full Text (subscription or payment may be required)
Even Partial Antenatal Steroid Treatment Benefits Preemies
MONDAY, Oct. 10, 2016 (HealthDay News) -- Even partial steroid treatment before birth can improve survival odds for extremely premature infants and reduce their risk of certain birth defects, according to a study published online Oct. 10 in JAMA Pediatrics.
Full Text (subscription or payment may be required)
U.S. Health Care System Is One of the Least Efficient Worldwide
MONDAY, Oct. 10, 2016 (HealthDay News) -- The U.S. health care system is one of the least efficient worldwide based on a Bloomberg index that assesses life expectancy, health care spending per capita, and relative spending as a share of gross domestic product, according to a report published by Bloomberg.
More Information
Daily Intranasal Steroid Tx Not Better for Allergy Relief
MONDAY, Oct. 10, 2016 (HealthDay News) -- Daily intranasal corticosteroids (INCS) are not superior to on-demand INCS or to antihistamine on demand for the treatment of pollen-related allergies in children, according to a study published online Oct. 3 in Allergy.
Full Text (subscription or payment may be required)
New Drug for Alcohol Use Disorder Appears Promising
FRIDAY, Oct. 7, 2016 (HealthDay News) -- An experimental drug -- a vasopressin antagonist called ABT-436 -- shows some promise in treating alcohol use disorder and smoking, according to a study published online Sept. 23 in Neuropsychopharmacology.
Full Text (subscription or payment may be required)
Global Burden of Disease Report Evaluates the World's Health
FRIDAY, Oct. 7, 2016 (HealthDay News) -- The United States lags behind other advanced nations when it comes to infant mortality and the life expectancy of its citizens, according to a comprehensive review of global health statistics published in the Oct. 8 issue of The Lancet.
Full Text
More Information
Price Increases Larger for Older Cancer Drugs Than Newer Ones
FRIDAY, Oct. 7, 2016 (HealthDay News) -- After adjusting for inflation, nearly two-thirds of 86 cancer medications had price increases between 2010 and 2015, according to a research letter published online Oct. 6 in JAMA Oncology.
Full Text
Long-Term Tamoxifen Does Lower Contralateral Breast Cancer Risk
FRIDAY, Oct. 7, 2016 (HealthDay News) -- Treatment with tamoxifen or aromatase inhibitors does cut breast cancer patients' risk of developing cancer in their other breast, according to findings published online Oct. 6 in JAMA Oncology.
Abstract
Full Text
Editorial (subscription or payment may be required)
Adding Daratumumab to Standard Tx Effective in Multiple Myeloma
FRIDAY, Oct. 7, 2016 (HealthDay News) -- Adding daratumumab to standard treatment for advanced cases of multiple myeloma may significantly improve patients' chances of a response and even recovery, according to a study published in the Oct. 6 issue of the New England Journal of Medicine.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Dermatologists Receive Considerable Industry Payments
THURSDAY, Oct. 6, 2016 (HealthDay News) -- Dermatologists receive considerable payments, mainly from the pharmaceutical industry, with variation in the nature and amount of payments, according to research published online Oct. 5 in JAMA Dermatology.
Abstract
Full Text
Editorial
DEA Planning to Cut Production of Opioid Medication
THURSDAY, Oct. 6, 2016 (HealthDay News) -- The U.S. Drug Enforcement Administration (DEA) says it has mandated significant cuts in the production of Schedule II opiate and opioid medication.
More Information
Burns, Blast Injuries on the Rise From Exploding E-Cigarettes
THURSDAY, Oct. 6, 2016 (HealthDay News) -- Electronic-cigarette devices are randomly and unexpectedly exploding, burning and injuring people near them when they detonate, according to a research letter published in the Oct. 6 issue of the New England Journal of Medicine.
Full Text
CDC Reviews Measles Outbreak in Amish Community
THURSDAY, Oct. 6, 2016 (HealthDay News) -- The measles outbreak that occurred in an Amish community in 2014 illustrates the ongoing threat the infection presents -- and the importance of routine vaccination, U.S. government researchers report in the Oct. 6 issue of the New England Journal of Medicine.
Abstract
Full Text
Editorial
Denver Clinic Boosts HPV Vaccination Rates
WEDNESDAY, Oct. 5, 2016 (HealthDay News) -- The way to increase the number of girls and boys who get the human papillomavirus (HPV) vaccine may be as simple as giving it as part of a routine bundle of vaccines, according to a study published online Oct. 5 in Pediatrics.
Full Text (subscription or payment may be required)
U.S. Smoking Rates Vary Across Counties Within States
WEDNESDAY, Oct. 5, 2016 (HealthDay News) -- Parts of the Midwest and South have the highest smoking rates in the United States, according to a study published online Oct. 1 in Cancer Epidemiology, Biomarkers & Prevention.
Full Text (subscription or payment may be required)
Opioid Use Disorder, Heroin Use Up Among Young Adults
WEDNESDAY, Oct. 5, 2016 (HealthDay News) -- Young adults in the United States are more likely to become addicted to prescription opioids than they were in years past, and they're also more likely to use heroin, according to a study recently published online in Addictive Behaviors.
Full Text (subscription or payment may be required)
Vitamin D Doesn't Improve Glucose Measures
WEDNESDAY, Oct. 5, 2016 (HealthDay News) -- Weekly doses of vitamin D do not improve oral glucose tolerance or markers of glycemic status among those at risk for diabetes, according to a study published online Sept. 26 in Diabetes, Obesity and Metabolism.
Abstract
Full Text (subscription or payment may be required)
Exenatide Does Not Promote Weight Loss in Schizophrenia
WEDNESDAY, Oct. 5, 2016 (HealthDay News) -- For antipsychotic-treated obese patients with schizophrenia, glucagon-like peptide-1 receptor agonists (GLP-1RAs) do not appear to promote weight loss, according to a study published online Sept. 26 in Diabetes, Obesity and Metabolism.
Abstract
Full Text (subscription or payment may be required)
Biologics Tied to Opportunistic Infection Risk in IBD
TUESDAY, Oct. 4, 2016 (HealthDay News) -- For adults with inflammatory bowel disease (IBD), biologic agents increase the risk of infection, especially opportunistic infection, but do not increase the risk of serious infection or malignancy, according to a review published in the October issue of Clinical Gastroenterology and Hepatology.
Abstract
Full Text
Botox, InterStim Compared in Female Urinary Incontinence
TUESDAY, Oct. 4, 2016 (HealthDay News) -- For women with refractory urgency urinary incontinence, onabotulinumtoxinA injections may help control leakage better than the implanted nerve stimulation device InterStim, according to a study published in the Oct. 4 issue of the Journal of the American Medical Association.
Abstract
Full Text (subscription or payment may be required)
Patient Satisfaction Up With Pharmacist-Managed Warfarin Tx
TUESDAY, Oct. 4, 2016 (HealthDay News) -- Pharmacist-managed warfarin anticoagulation therapy is associated with improved patient satisfaction, although the benefits in terms of control, safety, and mortality are unclear, according to a review published online Sept. 28 in the Journal of Clinical Pharmacy and Therapeutics.
Abstract
Full Text
Higher Bleeding Risk Seen With Rivaroxaban Versus Dabigatran
MONDAY, Oct. 3, 2016 (HealthDay News) -- Rivaroxaban may pose a slightly greater risk of serious bleeding than dabigatran in patients with atrial fibrillation, according to a study published online Oct. 3 in JAMA Internal Medicine.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Long-Term Pigmentation With Minocycline in Sclerotherapy
MONDAY, Oct. 3, 2016 (HealthDay News) -- For patients undergoing sclerotherapy, oral minocycline may induce significant pigmentation, according to a case report published online Sept. 28 in the Journal of Cutaneous Pathology.
Abstract
Full Text (subscription or payment may be required)
Risks, Benefits of Cangrelor Consistent in Angina, ACS
MONDAY, Oct. 3, 2016 (HealthDay News) -- For patients with stable angina (SA) or acute coronary syndrome (ACS), the benefits and risks of cangrelor are consistent, according to a study published in the Sept. 26 issue of JACC: Cardiovascular Interventions.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
2 mg/kg/day Azathioprine Best for Crohn's in Chinese Patients
MONDAY, Oct. 3, 2016 (HealthDay News) -- For Chinese patients with Crohn's disease (CD), 2 mg/kg/day azathioprine (AZA) seems more effective than 1 mg/kg/day, according to a study published online Sept. 21 in the Journal of Digestive Diseases.
Abstract
Full Text (subscription or payment may be required)
Statins Reduce Risk of Mortality in Multiple Myeloma
MONDAY, Oct. 3, 2016 (HealthDay News) -- Statin therapy is associated with reduced risk of all-cause and multiple myeloma (MM)-specific mortality, according to a study published online Sept. 19 in the Journal of Clinical Oncology.
Abstract
Full Text
Medication Adherence Stressful for Psoriasis Patients
MONDAY, Oct. 3, 2016 (HealthDay News) -- Adhering to medication regimens for the treatment of psoriasis can be an additional source of considerable emotional distress for patients, according to a study published online Sept. 24 in the British Journal of Dermatology.
Abstract
Full Text (subscription or payment may be required)
